DE602006021022D1 - Neue chemische verbindungen und ihre verwendungen als medikament - Google Patents

Neue chemische verbindungen und ihre verwendungen als medikament

Info

Publication number
DE602006021022D1
DE602006021022D1 DE602006021022T DE602006021022T DE602006021022D1 DE 602006021022 D1 DE602006021022 D1 DE 602006021022D1 DE 602006021022 T DE602006021022 T DE 602006021022T DE 602006021022 T DE602006021022 T DE 602006021022T DE 602006021022 D1 DE602006021022 D1 DE 602006021022D1
Authority
DE
Germany
Prior art keywords
compounds
medicament
family
relates
chemical compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006021022T
Other languages
English (en)
Inventor
Corinne Chaimbault
Cyrille Drouot
Laure Jamot
Rebecca Pruss
Celine Simon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trophos SA
Original Assignee
Trophos SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophos SA filed Critical Trophos SA
Publication of DE602006021022D1 publication Critical patent/DE602006021022D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/50—Nitrogen atoms bound to hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602006021022T 2005-07-01 2006-06-29 Neue chemische verbindungen und ihre verwendungen als medikament Active DE602006021022D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507023A FR2887879B1 (fr) 2005-07-01 2005-07-01 Nouveaux composes chimiques et leurs utilisations comme medicament,particulierement dans le traitement des maladies neurodegeneratives
PCT/FR2006/001521 WO2007003767A2 (fr) 2005-07-01 2006-06-29 Nouveaux composes chimiques et leurs utilisations comme medicament pour des maladies neurodegeneratives

Publications (1)

Publication Number Publication Date
DE602006021022D1 true DE602006021022D1 (de) 2011-05-12

Family

ID=36061529

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006021022T Active DE602006021022D1 (de) 2005-07-01 2006-06-29 Neue chemische verbindungen und ihre verwendungen als medikament

Country Status (10)

Country Link
US (1) US8691854B2 (de)
EP (1) EP1898908B1 (de)
JP (1) JP5635232B2 (de)
AT (1) ATE503479T1 (de)
AU (1) AU2006264803B2 (de)
CA (1) CA2613752C (de)
DE (1) DE602006021022D1 (de)
ES (1) ES2363995T3 (de)
FR (1) FR2887879B1 (de)
WO (1) WO2007003767A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7956051B2 (en) 2008-01-24 2011-06-07 Allergan, Inc. Therapeutic amides and related compounds
CN102702058A (zh) * 2009-10-27 2012-10-03 厦门大学 4-甲氧基肉桂醛缩氨基硫脲的制备方法
WO2012069150A2 (en) 2010-11-22 2012-05-31 Powerpore Gmbh Cytoprotectant agents for the prevention of drug-associated side-effects
GB201405991D0 (en) 2014-04-03 2014-05-21 Cambridge Entpr Ltd Novel compounds
CN113999187A (zh) * 2021-11-30 2022-02-01 江西农业大学 一种噻唑腙衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006426A1 (en) * 2001-07-13 2003-01-23 Axxima Pharmaceuticals Ag Aromatic guanylhydrazones as effective compounds against neurodiseases
CA2501803A1 (en) * 2002-10-09 2004-04-22 Pfizer Products Inc. Thiazole compounds for the treatment of neurodegenerative disorders
GB0300804D0 (en) * 2003-01-14 2003-02-12 Novo Pharmaceuticals De Ltd Compounds and their use

Also Published As

Publication number Publication date
US20090203747A1 (en) 2009-08-13
ES2363995T3 (es) 2011-08-22
JP5635232B2 (ja) 2014-12-03
US8691854B2 (en) 2014-04-08
JP2009500312A (ja) 2009-01-08
CA2613752A1 (fr) 2007-01-11
AU2006264803A1 (en) 2007-01-11
WO2007003767A2 (fr) 2007-01-11
FR2887879B1 (fr) 2008-09-26
WO2007003767A3 (fr) 2007-05-03
CA2613752C (fr) 2015-10-06
ATE503479T1 (de) 2011-04-15
FR2887879A1 (fr) 2007-01-05
AU2006264803B2 (en) 2012-01-19
EP1898908B1 (de) 2011-03-30
EP1898908A2 (de) 2008-03-19

Similar Documents

Publication Publication Date Title
ATE473975T1 (de) Chemische verbindungen
ATE398613T1 (de) Chemische verbindungen
TW200800998A (en) Phenylalanine derivatives
BRPI0610850A2 (pt) derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados
WO2007068894A3 (en) Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
BRPI0511874A (pt) derivados da pirrolopiridina
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
GB201021104D0 (en) Novel compounds for the treatment of neurodegenerative diseases
NO20085100L (no) Nye forbindelser
MX2010009752A (es) Compuestos de oxadiazoantraceno para el tratamiento de diabetes.
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
UA86595C2 (ru) Гамма-кристаллическая форма гидрохлорида ивабрадина, способ ее получения и фармацевтическая композиция, которая ее содержит
TW200738659A (en) Novel compounds
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
SG161217A1 (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
GB0620385D0 (en) Novel compounds
MX339644B (es) Sales de xantilio 3,6-disustituidas.
GEP20135832B (en) Benzothiazines derivatives, preparation thereof, and their application as drugs
DE602006021022D1 (de) Neue chemische verbindungen und ihre verwendungen als medikament
PL1753719T3 (pl) Podstawione pirolidyn-2-ony
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
TW200634002A (en) Chemical compounds